Showing results (321-330 of 330) with videos related to
Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 330 results.
Cancer Discovery|October 4, 2023
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast CancerBrandie C Taylor, Xiaopeng Sun, Paula I Gonzalez-Ericsson, et al.Biology|October 10, 2020
Clinical Veterinary Boron Neutron Capture Therapy (BNCT) Studies in Dogs with Head and Neck Cancer: Bridging the Gap between Translational and Clinical StudiesAmanda E Schwint, Andrea Monti Hughes, Marcela A Garabalino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2020
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related GenesNadine M Tung, Mark E Robson, Steffen Ventz, et al.NPJ Breast Cancer|December 30, 2022
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013Foluso O Ademuyiwa, Feng Gao, Cherease R Street, et al.Nature Medicine|October 19, 2023
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trialJason J Luke, Manish R Patel, George R Blumenschein, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2024
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022R A Freedman, H M Heiling, T Li, et al.Breast (Edinburgh, Scotland)|July 25, 2026
Patient-reported outcomes from the TBCRC 022 study of neratinib and ado-trastuzumab emtansine for HER2-positive breast cancer brain metastasesThomas Grinda, Hillary M Heiling, Nabihah Tayob, et al.Cancer Research Communications|April 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast CancerElizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025William J Gradishar, Meena S Moran, Jame Abraham, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2026
Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.Pageof 33